Severe malaria treatment with rectal artesunate and artemisinin-based combination therapy in remote settings: an effectiveness-implementation hybrid type 3 study protocol (SEMA ReACT).
Saved in:
| Title: | Severe malaria treatment with rectal artesunate and artemisinin-based combination therapy in remote settings: an effectiveness-implementation hybrid type 3 study protocol (SEMA ReACT). |
|---|---|
| Authors: | Hachizovu S; National Health Research and Training Institute, Lusaka, Zambia. sebastianhachizovu4@gmail.com.; Global Health Institute, University of Antwerp, Antwerp, Belgium. sebastianhachizovu4@gmail.com., Manyando C; National Health Research and Training Institute, Lusaka, Zambia., Nambozi M; National Health Research and Training Institute, Lusaka, Zambia., Khondowe S; National Health Research and Training Institute, Lusaka, Zambia., Hamainza B; Programme Coordination Unit, Ministry of Health, Lusaka, Zambia., Mukumbuta D; National Malaria Elimination Centre, Ministry of Health, Lusaka, Zambia., Rietveld H; MMV Medicines for Malaria Venture, Geneva, Switzerland., Mukomena Sompwe E; National Malaria Control Programme, Ministry of Health, Kinshasa, Democratic Republic of Congo.; University of Lubumbashi, Lubumbashi, Democratic Republic of Congo., Kikunda G; National Malaria Control Programme, Lubumbashi, Haut-Katanga Province, Democratic Republic of Congo., Muhindo-Mavoko H; University of Kinshasa, Kinshasa, Democratic Republic of Congo., Luzolo Khote F; Global Health Institute, University of Antwerp, Antwerp, Belgium.; University of Kinshasa, Kinshasa, Democratic Republic of Congo., Kanyamukenge D; Global Health Institute, University of Antwerp, Antwerp, Belgium.; University of Lubumbashi, Lubumbashi, Democratic Republic of Congo., Bastiaens H; Global Health Institute, University of Antwerp, Antwerp, Belgium., Kakudji A; University of Lubumbashi, Lubumbashi, Democratic Republic of Congo., Maseko T; Global Health Institute, University of Antwerp, Antwerp, Belgium., Makenga G; Global Health Institute, University of Antwerp, Antwerp, Belgium.; National Institute for Medical Research, Tanga, Tanzania., Baraka V; National Institute for Medical Research, Tanga, Tanzania., Mutombo A; University of Lubumbashi, Lubumbashi, Democratic Republic of Congo., Duparc S; MMV Medicines for Malaria Venture, Geneva, Switzerland., Van Geertruyden JP; Global Health Institute, University of Antwerp, Antwerp, Belgium. |
| Source: | Malaria journal [Malar J] 2026 Feb 09; Vol. 25 (1). Date of Electronic Publication: 2026 Feb 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
